Results 51 to 60 of about 4,727 (145)

A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges

Therapeutic Advances in Respiratory Disease, 2013
Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension (PH). Misdiagnosis of the disease is common since PVOD presents with clinical and radiographic features mimicking idiopathic pulmonary arterial hypertension or even PH due ...
Evdokia Sourla, Asimina Paspala, Afroditi Boutou, Paschalina Kontou, Ioannis Stanopoulos, Georgia Pitsiou   +5 more
doaj   +1 more source

The Evolving Landscape of Pulmonary Hypertension Treatment: From Vasodilation to Disease Modification

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT Pulmonary hypertension (PH) is a complex disorder associated with significant morbidity and mortality. PH is characterized by an elevated pulmonary vascular load, leading to right ventricular dysfunction and remodeling, with right heart failure and premature death if left untreated.
Surya Ayalasomayajula, Ednan K. Bajwa, Alexandra G. Cornell, Maria Jose Loureiro, Samuel S. Kim, Julia Richmond DiBello, Eric Sterner, Richard Chen, Islam R. Younis   +8 more
wiley   +1 more source

One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease

Brazilian Journal of Medical and Biological Research, 2005
We hypothesized that chronic oral administration of the phosphodiesterase-5 inhibitor sildenafil could improve the exercise capacity and pulmonary hemodynamics in patients with pulmonary arterial hypertension (PAH) on the basis of previous short-term ...
A.C. Barreto, S.M. Franchi, C.R.P. Castro, A.A. Lopes   +3 more
doaj   +1 more source

The Role of Invasive Procedures in the Treatment of Complicated Gastrointestinal Graft‐Versus‐Host Disease in Pediatric Patients

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Background Gastrointestinal graft‐versus‐host disease (GI GVHD) following hematopoietic stem cell transplant is typically managed with medical therapy, but surgery and angioembolization may be warranted in selected cases with life‐threatening complications.
Gaia Brunetti, Giorgio Persano, Chiara Grimaldi, Pier Luigi Di Paolo, Carmen Malaspina, Francesco Quagliarella, Valerio Balassone, Anna Chiara Iolanda Contini, Gian Luigi Natali, Rita Alaggio, Ivan Pietro Aloi, Tamara Caldaro, Alessandro Crocoli   +12 more
wiley   +1 more source

Isolated pulmonary veno-occlusive disease and pulmonary arterial thrombosis in systemic sclerosis – a lethal combination

International Medical Case Reports Journal, 2010
Arun JeevaganGeneral Medicine, Ipswich NHS Hospital, UKBackground: Isolated pulmonary hypertension secondary to systemic sclerosis is not uncommon. Our patient with systemic sclerosis presented with a very aggressive form of pulmonary hypertension due to
Arun Jeevagan
doaj  

“Intrapericardial Approach” for Venous Outflow Reconstruction in Living‐Donor Liver Transplantation for Budd‐Chiari Syndrome: Surgical Techniques and LongTerm Outcomes

Annals of Gastroenterological Surgery, Volume 10, Issue 4, Page 1356-1364, July 2026.
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata, Tetsuya Tajima, Satoshi Ogiso, Shinji Uemoto, Etsuro Hatano   +4 more
wiley   +1 more source

Evacuation of a Large Intracardiac Thrombus at Cavoatrial Junction Using a Coaxial Aspiration System Through an ŌNŌ Retrieval Device in a Pediatric Patient

Catheterization and Cardiovascular Interventions, Volume 108, Issue 1, Page 174-177, July 1, 2026.
ABSTRACT Intracardiac thrombus in the right heart has a great risk of embolizing to the pulmonary circulation leading to great morbidity and mortality. Removal of large thrombi incurs an increased risk of embolization, especially if the clot is more acute and not fully adherent.
Saloni K. Trivedi, Jesus C. Jaile, Minghua Angela Hao, Ernesto Mejia   +3 more
wiley   +1 more source

DIAGNOSTIC SPECIFICS OF PULMONARY VENO-OCCLUSIVE DISEASE

Российский кардиологический журнал, 2012
The authors present the two-year follow-up of a female patient with severe pulmonary hypertension and a rare pathology – pulmonary veno-occlusive disease. Due to the treatment with low-dose prednisolone, in combination with warfarin, coraxan, and oxygen,
E. A. Zhuk, N. V. Kirichenko, S. E. Myasoedova, T. A. Pobedinskaya, V. P. Vasilyeva   +4 more
doaj  

Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab

BMC Pulmonary Medicine, 2018
Background Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare cause of pulmonary hypertension that is associated with malignancies and is marked by the presence of non-occlusive tumor emboli and fibrocellular intimal proliferation of small ...
Dante A. Suffredini, Jung-Min Lee, Cody J. Peer, Drew Pratt, David E. Kleiner, Jason M. Elinoff, Michael A. Solomon   +6 more
doaj   +1 more source

Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease. [PDF]

PLoS ONE, 2014
Pulmonary veno-occlusive disease (PVOD) is a rare condition of pulmonary arterial hypertension (PAH), in which post-capillary veins are affected. Since the therapeutic approach in PVOD differs from other forms of PAH, it is crucial to establish the ...
Heidi Lederer, Bettina Muggli, Rudolf Speich, Ula Treder, Hans Stricker, Jeroen Goede, Silvia Ulrich, Simon F Stämpfli, Alexander Breitenstein   +8 more
doaj   +1 more source